Ryota Matsuda
Kitakyushu, 8020077, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Multiple angiosarcomas of both breasts: a case report.
Journal: Surgical case reports
Published: March 21, 2023
Erratum to "ERAP2 is a novel target involved in autophagy and activation of pancreatic stellate cells via UPR signaling pathway" [Pancreatology 22 (1) (2022 Jan) 9-19].
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: August 23, 2022
Relationship between cellular morphology and abnormality of SWI/SNF complex subunits in pancreatic undifferentiated carcinoma.
Journal: Journal of cancer research and clinical oncology
Published: August 22, 2021
ERAP2 is a novel target involved in autophagy and activation of pancreatic stellate cells via UPR signaling pathway.
Journal: Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]
Published: June 13, 2021
Prognostic implications of the coexisting precursor lesion types in invasive gallbladder cancer.
Journal: Human pathology
Published: February 19, 2021
Collision of a pancreatic ductal adenocarcinoma and a pancreatic neuroendocrine tumor associated with multiple endocrine neoplasm type 1.
Journal: Clinical journal of gastroenterology
Published: June 13, 2020
Chronic inflammatory changes and oxidative stress in the background of "pancreatic ductal adenocarcinoma concomitant with intraductal papillary mucinous neoplasm".
Journal: Virchows Archiv : an international journal of pathology
Published: January 23, 2020
Is remnant pancreatic cancer after pancreatic resection more frequent in early-stage pancreatic cancer than in advanced-stage cancer?
Journal: Annals of gastroenterological surgery
Published: October 29, 2019
High-risk lesions in the remnant pancreas: fate of the remnant pancreas after pancreatic resection for pancreatic cancer and intraductal papillary mucinous neoplasms.
Journal: Surgery today
Published: April 13, 2019
Neoadjuvant Chemotherapy with Gemcitabine Plus Nab-Paclitaxel for Borderline Resectable Pancreatic Cancer Potentially Improves Survival and Facilitates Surgery.
Journal: Annals of surgical oncology
Published: November 08, 2018
Concomitant Intraductal Papillary Mucinous Neoplasm in Pancreatic Ductal Adenocarcinoma Is an Independent Predictive Factor for the Occurrence of New Cancer in the Remnant Pancreas.
Journal: Annals of surgery
Published: October 12, 2018
Last Updated: 09/26/2026